Association between the treatment length and cumulative dose of pegylated interferon alpha-2b plus ribavirin and their effectiveness as a combination treatment for Japanese chronic hepatitis C patients: Project of the Kyushu University Liver Disease Study Group

Treatment Length ◽

Interferon Alpha 2B ◽

Disease Study ◽

P279 Reduction of hepatocellular carcinoma recurrence by pegylated interferon alpha-2b plus ribavirin treatment for chronic hepatitis C patients

International Journal of Antimicrobial Agents ◽

10.1016/s0924-8579(13)70520-x ◽

2013 ◽

Vol 42 ◽

pp. S130

Author(s):

N. Furusyo ◽

M. Murata ◽

E. Ogawa ◽

H. Nomura ◽

J. Hayashi

Keyword(s):

Hepatocellular Carcinoma ◽

Chronic Hepatitis ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Interferon Alpha ◽

Pegylated Interferon ◽

Interferon Alpha 2B ◽

Hepatocellular Carcinoma Recurrence ◽

An early prognosis for the treatment of Chronic Hepatitis C patients with Pegylated Interferon-.ALPHA.2b plus Ribavirin-Monitoring analysis by the serum HCV core antigen values-

Kanzo ◽

10.2957/kanzo.47.355 ◽

2006 ◽

Vol 47 (7) ◽

pp. 355-356

Author(s):

Tatsuya Fujino ◽

Kazuto Goto ◽

Eiichiro Arimura ◽

Yumiko Sakiyama ◽

Ryosuke Takemoto ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Interferon Alpha ◽

Pegylated Interferon ◽

Core Antigen ◽

Interferon Alpha 2B ◽

Hcv Core Antigen ◽

Zinc Supplementation Prevents the Increase of Transaminase in Chronic Hepatitis C Patients during Combination Therapy with Pegylated Interferon .ALPHA.-2b and Ribavirin

Journal of Nutritional Science and Vitaminology ◽

10.3177/jnsv.53.213 ◽

2007 ◽

Vol 53 (3) ◽

pp. 213-218 ◽

Cited By ~ 28

Author(s):

Yasuko MURAKAMI ◽

Tomoko KOYABU ◽

Aiko KAWASHIMA ◽

Naoko KAKIBUCHI ◽

Takayo KAWAKAMI ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C ◽

Combination Therapy ◽

Chronic Hepatitis C ◽

Interferon Alpha ◽

Zinc Supplementation ◽

Pegylated Interferon ◽

Interferon Alpha 2B ◽

PIN53 Cost-Effectiveness Analysis of Pegylated Interferon Alpha-2A Versus Pegylated Interferon Alpha-2B in the Treatment of Chronic Hepatitis C Patients in Poland

Value in Health ◽

10.1016/j.jval.2011.08.239 ◽

2011 ◽

Vol 14 (7) ◽

pp. A274-A275

Author(s):

T. Macioch ◽

J. Paweska ◽

M. Niewada ◽

H. Berak ◽

M. Szkultecka-Debek ◽

...

Keyword(s):

Chronic Hepatitis ◽

Cost Effectiveness ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Interferon Alpha ◽

Pegylated Interferon ◽

Interferon Alpha 2B ◽

Effectiveness Analysis ◽

An inadequate dose of ribavirin is related to virological relapse by chronic hepatitis C patients treated with pegylated interferon alpha-2b and ribavirin

Journal of Infection and Chemotherapy ◽

10.1007/s10156-012-0396-5 ◽

2012 ◽

Vol 18 (5) ◽

pp. 689-697 ◽

Cited By ~ 4

Author(s):

Eiichi Ogawa ◽

Norihiro Furusyo ◽

Jun Hayashi ◽

Eiji Kajiwara ◽

Kazuhiro Takahashi ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Interferon Alpha ◽

Pegylated Interferon ◽

Interferon Alpha 2B ◽

Virological Relapse ◽

The longitudinal quantitative assessment by transient elastography of chronic hepatitis C patients treated with pegylated interferon alpha-2b and ribavirin

Antiviral Research ◽

10.1016/j.antiviral.2009.04.002 ◽

2009 ◽

Vol 83 (2) ◽

pp. 127-134 ◽

Cited By ~ 91

Author(s):

Eiichi Ogawa ◽

Norihiro Furusyo ◽

Kazuhiro Toyoda ◽

Hiroaki Takeoka ◽

Shinji Maeda ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Interferon Alpha ◽

Quantitative Assessment ◽

Transient Elastography ◽

Pegylated Interferon ◽

Interferon Alpha 2B ◽

P1108 EFFICACY AND TOLERABILITY OF TELAPREVIR-BASED TRIPLE THERAPY FOR ADVANCED FIBROSIS STAGE CHRONIC HEPATITIS C PATIENTS: RESULTS OF THE KYUSHU UNIVERSITY LIVER DISEASE STUDY GROUP

Journal of Hepatology ◽

10.1016/s0168-8278(14)61268-x ◽

2014 ◽

Vol 60 (1) ◽

pp. S447

Author(s):

N. Furusyo ◽

E. Ogawa ◽

M. Nakamuta ◽

E. Kajiwara ◽

H. Nomura ◽

...

Keyword(s):

Chronic Hepatitis ◽

Liver Disease ◽

Hepatitis C ◽

Triple Therapy ◽

Chronic Hepatitis C ◽

Fibrosis Stage ◽

Study Group ◽

Advanced Fibrosis ◽

Disease Study ◽

Insulin resistance undermines the advantages of IL28B polymorphism in the pegylated interferon alpha-2b and ribavirin treatment of chronic hepatitis C patients with genotype 1

Journal of Hepatology ◽

10.1016/j.jhep.2012.04.027 ◽

2012 ◽

Vol 57 (3) ◽

pp. 534-540 ◽

Cited By ~ 29

Author(s):

Eiichi Ogawa ◽

Norihiro Furusyo ◽

Masayuki Murata ◽

Hiroaki Ikezaki ◽

Takeshi Ihara ◽

...

Keyword(s):

Insulin Resistance ◽

Chronic Hepatitis ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Pegylated Interferon ◽

Genotype 1 ◽

Interferon Alpha 2B ◽

Il28b Polymorphism ◽

Lead-in treatment with interferon-β/ribavirin may modify the early hepatitis C virus dynamics in pegylated interferon alpha-2b/ribavirin combination for chronic hepatitis C patients with the IL28B minor genotype

Journal of Gastroenterology and Hepatology ◽

10.1111/jgh.12039 ◽

2013 ◽

Vol 28 (3) ◽

pp. 443-449 ◽

Cited By ~ 1

Author(s):

Norio Itokawa ◽

Masanori Atsukawa ◽

Akihito Tsubota ◽

Chisa Kondo ◽

Satomi Hashimoto ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C Virus ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Pegylated Interferon ◽

Virus Dynamics ◽

Interferon Β ◽

Interferon Alpha 2B ◽

Interferon alpha plus ribavirin combination treatment of Japanese chronic hepatitis C patients with HCV genotype 2: A project of the Kyushu University Liver Disease Study Group

World Journal of Gastroenterology ◽

10.3748/wjg.v12.i5.784 ◽

2006 ◽

Vol 12 (5) ◽

pp. 784 ◽

Cited By ~ 13

Author(s):

Norihiro Furusyo

Keyword(s):

Chronic Hepatitis ◽

Liver Disease ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Combination Treatment ◽

Study Group ◽

Genotype 2 ◽

Hcv Genotype 2 ◽

Disease Study ◽